Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wolfgang Hinkelbein

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Frontiers of Radiation Therapy and Oncology|June 12, 2008
Hormone-refractory and metastatic prostate cancer - palliative radiotherapyLutz Moser, Tina Schubert, Wolfgang Hinkelbein
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 7, 2007
Phase I trial of radiochemotherapy with bendamustine in patients with recurrent squamous cell carcinoma of the head and neckDirk Bottke, Kathrin Bathe, Thomas Wiegel, et al.
Frontiers of Radiation Therapy and Oncology|June 12, 2008
Radiotherapy in biochemical recurrences after surgery for prostate cancerStefan Höcht, Gunnar Lohm, Lutz Moser, et al.
International Journal of Colorectal Disease|December 8, 2007
Adjuvant and neoadjuvant chemoradiation or radiotherapy in rectal cancer--a review focusing on open questionsLutz Moser, Jörg-Peter Ritz, Wolfgang Hinkelbein, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 21, 2002
The value of PSA measurements at 30 Gy, 50 Gy and 60 Gy for dose limitation in patients with radiotherapy for PSA increase after radical prostatectomyThomas Wiegel, Dirk Bottke, Patrick Bandlow, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|February 1, 2006
Interindividual variability of lymph drainages in patients with cervical cancer. Implication on irradiation planningSimone Marnitz, Christhardt Köhler, Achim Schneider, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|January 13, 2006
Uterus necrosis after radiochemotherapy in two patients with advanced cervical cancerSimone Marnitz, Christhardt Köhler, Jürgen Füller, et al.
The Lancet. Oncology|April 1, 2006
Radiation-related damage to dentitionAndrej M Kielbassa, Wolfgang Hinkelbein, Elmar Hellwig, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|April 14, 2005
Is a diagnostic CT of the brain indicated in patients with choroidal metastases before radiotherapy?Dirk Bottke, Thomas Wiegel, Klaus-Martin Kreusel, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 15, 2015
The PSA-response to salvage radiotherapy after radical prostatectomy correlates with freedom from progression and overall survivalDetlef Bartkowiak, Dirk Bottke, Reinhard Thamm, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Frontiers of Radiation Therapy and Oncology|June 12, 2008
Hormone-refractory and metastatic prostate cancer - palliative radiotherapyLutz Moser, Tina Schubert, Wolfgang Hinkelbein
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 7, 2007
Phase I trial of radiochemotherapy with bendamustine in patients with recurrent squamous cell carcinoma of the head and neckDirk Bottke, Kathrin Bathe, Thomas Wiegel, et al.
Frontiers of Radiation Therapy and Oncology|June 12, 2008
Radiotherapy in biochemical recurrences after surgery for prostate cancerStefan Höcht, Gunnar Lohm, Lutz Moser, et al.
International Journal of Colorectal Disease|December 8, 2007
Adjuvant and neoadjuvant chemoradiation or radiotherapy in rectal cancer--a review focusing on open questionsLutz Moser, Jörg-Peter Ritz, Wolfgang Hinkelbein, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 21, 2002
The value of PSA measurements at 30 Gy, 50 Gy and 60 Gy for dose limitation in patients with radiotherapy for PSA increase after radical prostatectomyThomas Wiegel, Dirk Bottke, Patrick Bandlow, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|February 1, 2006
Interindividual variability of lymph drainages in patients with cervical cancer. Implication on irradiation planningSimone Marnitz, Christhardt Köhler, Achim Schneider, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|January 13, 2006
Uterus necrosis after radiochemotherapy in two patients with advanced cervical cancerSimone Marnitz, Christhardt Köhler, Jürgen Füller, et al.
The Lancet. Oncology|April 1, 2006
Radiation-related damage to dentitionAndrej M Kielbassa, Wolfgang Hinkelbein, Elmar Hellwig, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|April 14, 2005
Is a diagnostic CT of the brain indicated in patients with choroidal metastases before radiotherapy?Dirk Bottke, Thomas Wiegel, Klaus-Martin Kreusel, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 15, 2015
The PSA-response to salvage radiotherapy after radical prostatectomy correlates with freedom from progression and overall survivalDetlef Bartkowiak, Dirk Bottke, Reinhard Thamm, et al.
Pageof 5